We report a multimodal analysis profiling how genetic risk factors for Alzheimer’s disease influence the development of neuropathology and clinical performance in the Brains for Dementia Research (BDR) study, highlighting a shared pathway between APOE and the development of tauopathy and beta-amyloidosis and an independent pathway associated with tauopathy. The gene discussed is APOE; the disease is tauopathy.